Birchview Capital, LP Diversified Active

Location: Burlington, VT

CIK: 0001618205 · Show all filings

Period: Q1 2021 (← Previous) (Next →)

Filing Date: May 14, 2021

Total Value: $168M (100.0% shares, 0.0% debt)

Holdings (54)

BMY BRISTOL-MYERS SQUIBB CO 29.8%
Value $50.14M Shares 794,186 Share Price $63.13 * Est. Cost/Share $44.70 Unrealized @ Report Date +14.2%
— BIODESIX INC 13.3%
Value $22.44M Shares 1,104,953 Share Price $20.31 Est. Cost/Share $20.16 Unrealized @ Report Date —
— ACCELERATE DIAGNOSTICS INC 10.9%
Value $18.39M Shares 2,213,326 Share Price $8.31 Est. Cost/Share $19.28 Unrealized @ Report Date —
NBIX NEUROCRINE BIOSCIENCES INC 4.6%
Value $7.799M Shares 80,200 Share Price $97.24 * Est. Cost/Share $70.20 Unrealized @ Report Date +49.4%
— QUIDEL CORP 4.5%
Value $7.502M Shares 58,644 Share Price $127.92 Est. Cost/Share $66.26 Unrealized @ Report Date —
ACAD ACADIA PHARMACEUTICALS INC 2.7%
Value $4.567M Shares 177,000 Share Price $25.80 * Est. Cost/Share $41.41 Unrealized @ Report Date +6.3%
FHTX FOGHORN THERAPEUTICS INC 2.5%
Value $4.14M Shares 314,143 Share Price $13.18 * Est. Cost/Share $19.16 Unrealized @ Report Date -14.5%
— ALBIREO PHARMA INC 2.3%
Value $3.913M Shares 111,000 Share Price $35.25 Est. Cost/Share $34.34 Unrealized @ Report Date —
BIIB BIOGEN INC 2.0%
Value $3.385M Shares 12,100 Share Price $279.75 * Est. Cost/Share $287.32 Unrealized @ Report Date -6.1%
UTHR UNITED THERAPEUTICS CORP 1.8%
Value $3.011M Shares 18,000 Share Price $167.28 Est. Cost/Share $93.09 Unrealized @ Report Date +79.1%
— ACCELERON PHARMA INC 1.5%
Value $2.532M Shares 18,672 Share Price $135.60 Est. Cost/Share $36.87 Unrealized @ Report Date —
CGEM CULLINAN ONCOLOGY INC 1.5%
Value $2.505M Shares 60,114 Share Price $41.67 * Est. Cost/Share $40.60 Unrealized @ Report Date 0.0%
— KARYOPHARM THERAPEUTICS INC 1.4%
Value $2.42M Shares 230,000 Share Price $10.52 Est. Cost/Share $15.94 Unrealized @ Report Date —
— BLUEBIRD BIO INC 1.4%
Value $2.276M Shares 75,500 Share Price $30.15 Est. Cost/Share $55.04 Unrealized @ Report Date —
— AMARIN CORP PLC 1.1%
Value $1.863M Shares 300,000 Share Price $6.21 Est. Cost/Share $7.50 Unrealized @ Report Date —
— NEKTAR THERAPEUTICS 1.1%
Value $1.84M Shares 92,000 Share Price $20.00 Est. Cost/Share $20.00 Unrealized @ Report Date —
MASI MASIMO CORP 1.1%
Value $1.837M Shares 8,000 Share Price $229.63 * Est. Cost/Share $24.68 Unrealized @ Report Date +917.9%
— IMMUNOGEN INC 0.9%
Value $1.539M Shares 190,000 Share Price $8.10 Est. Cost/Share $2.74 Unrealized @ Report Date —
— CHEMOCENTRYX INC 0.9%
Value $1.537M Shares 30,000 Share Price $51.23 Est. Cost/Share $39.66 Unrealized @ Report Date —
— ARENA PHARMACEUTICALS INC 0.9%
Value $1.527M Shares 22,000 Share Price $69.41 Est. Cost/Share $41.96 Unrealized @ Report Date —
— PROGENITY INC 0.8%
Value $1.285M Shares 270,000 Share Price $4.76 Est. Cost/Share $5.27 Unrealized @ Report Date —
HROW HARROW HEALTH INC 0.7%
Value $1.215M Shares 180,000 Share Price $6.75 * Est. Cost/Share $6.05 Unrealized @ Report Date +35.5%
VNDA VANDA PHARMACEUTICALS INC 0.7%
Value $1.202M Shares 80,000 Share Price $15.03 * Est. Cost/Share $14.87 Unrealized @ Report Date +8.9%
CORT CORCEPT THERAPEUTICS INC 0.7%
Value $1.19M Shares 50,000 Share Price $23.80 * Est. Cost/Share $6.85 Unrealized @ Report Date +289.5%
— SOLENO THERAPEUTICS INC 0.7%
Value $1.105M Shares 876,899 Share Price $1.26 Est. Cost/Share $2.18 Unrealized @ Report Date —
— ANGION BIOMEDICA CORP 0.7%
Value $1.095M Shares 60,615 Share Price $18.06 Est. Cost/Share $18.06 Unrealized @ Report Date —
— EQUITRANS MIDSTREAM CORPORATIO 0.6%
Value $1.086M Shares 133,050 Share Price $8.16 Est. Cost/Share $8.31 Unrealized @ Report Date —
KALV KALVISTA PHARMACEUTICALS INC 0.6%
Value $1.028M Shares 40,000 Share Price $25.70 * Est. Cost/Share $18.69 Unrealized @ Report Date +40.6%
— CONTINENTAL RESOURCES INC 0.6%
Value $999K Shares 38,600 Share Price $25.88 Est. Cost/Share $17.54 Unrealized @ Report Date —
ARVN ARVINAS INC 0.6%
Value $992K Shares 15,000 Share Price $66.13 * Est. Cost/Share $16.46 Unrealized @ Report Date +364.8%
— G1 THERAPEUTICS INC 0.6%
Value $962K Shares 40,000 Share Price $24.05 Est. Cost/Share $33.05 Unrealized @ Report Date —
— CONTRAFECT CORP 0.6%
Value $960K Shares 200,000 Share Price $4.80 Est. Cost/Share $0.81 Unrealized @ Report Date —
OVV OVINTIV INC 0.5%
Value $818K Shares 34,350 Share Price $23.81 * Est. Cost/Share $6.97 Unrealized @ Report Date +206.8%
— INARI MEDICAL INC 0.4%
Value $749K Shares 7,000 Share Price $107.00 Est. Cost/Share $48.40 Unrealized @ Report Date —
TGTX TG THERAPEUTICS INC 0.4%
Value $723K Shares 15,000 Share Price $48.20 Est. Cost/Share $13.75 Unrealized @ Report Date +249.4%
— ASPIRA WOMENS HEALTH INC 0.4%
Value $696K Shares 103,104 Share Price $6.75 Est. Cost/Share $3.84 Unrealized @ Report Date —
— BIOHAVEN PHARMACEUTICAL HOLDING CO LTD 0.4%
Value $684K Shares 10,000 Share Price $68.40 Est. Cost/Share $54.40 Unrealized @ Report Date —
PGNY PROGYNY INC 0.4%
Value $668K Shares 15,000 Share Price $44.53 * Est. Cost/Share $23.98 Unrealized @ Report Date +94.9%
ALKS ALKERMES PLC 0.4%
Value $654K Shares 35,000 Share Price $18.69 * Est. Cost/Share $20.47 Unrealized @ Report Date 0.0%
— PIONEER NATURAL RESOURCES CO 0.4%
Value $604K Shares 3,800 Share Price $158.95 Est. Cost/Share $145.33 Unrealized @ Report Date —
STOK STOKE THERAPEUTICS INC 0.3%
Value $583K Shares 15,000 Share Price $38.87 * Est. Cost/Share $24.71 Unrealized @ Report Date +130.4%
XNCR XENCOR INC 0.3%
Value $530K Shares 12,300 Share Price $43.09 * Est. Cost/Share $15.78 Unrealized @ Report Date +200.2%
LSF LAIRD SUPERFOOD INC 0.3%
Value $525K Shares 14,000 Share Price $37.50 Est. Cost/Share $37.50 Unrealized @ Report Date —
— TRANSLATE BIO INC 0.3%
Value $495K Shares 30,000 Share Price $16.50 Est. Cost/Share $9.97 Unrealized @ Report Date —
FOLD AMICUS THERAPEUTICS INC 0.2%
Value $375K Shares 38,000 Share Price $9.87 * Est. Cost/Share $14.56 Unrealized @ Report Date +6.3%
APLS APELLIS PHARMACEUTICALS INC 0.2%
Value $343K Shares 8,000 Share Price $42.88 * Est. Cost/Share $27.68 Unrealized @ Report Date +70.9%
IFRX INFLARX NV 0.2%
Value $273K Shares 70,000 Share Price $3.90 * Est. Cost/Share $3.70 Unrealized @ Report Date +38.2%
ARQT ARCUTIS BIOTHERAPEUTICS INC 0.2%
Value $260K Shares 9,000 Share Price $28.89 * Est. Cost/Share $31.23 Unrealized @ Report Date 0.0%
PTGX PROTAGONIST THERAPEUTICS INC 0.2%
Value $259K Shares 10,000 Share Price $25.90 * Est. Cost/Share $25.31 Unrealized @ Report Date 0.0%
— DICERNA PHARMACEUTICALS INC 0.2%
Value $256K Shares 10,000 Share Price $25.60 Est. Cost/Share $4.60 Unrealized @ Report Date —
— YIELD10 BIOSCIENCE INC 0.1%
Value $238K Shares 18,952 Share Price $12.56 Est. Cost/Share $0.24 Unrealized @ Report Date —
BCRX BIOCRYST PHARMACEUTICALS INC 0.1%
Value $203K Shares 20,000 Share Price $10.15 Est. Cost/Share $6.02 Unrealized @ Report Date +71.4%
— THERAPEUTICSMD INC 0.1%
Value $134K Shares 100,000 Share Price $1.34 Est. Cost/Share $1.34 Unrealized @ Report Date —
— CONCERT PHARMACEUTICALS INC 0.1%
Value $100K Shares 20,000 Share Price $5.00 Est. Cost/Share $5.00 Unrealized @ Report Date —